These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9748012)
41. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Greene DA; Arezzo JC; Brown MB Neurology; 1999 Aug; 53(3):580-91. PubMed ID: 10449124 [TBL] [Abstract][Full Text] [Related]
42. Correlation of clinical and neurophysiological findings with health-related quality of life in patients with diabetic polyneuropathy. Vukojević Z; Pekmezović T; Nikolić A; Perić S; Basta I; Marjanović I; Lavrnić D Vojnosanit Pregl; 2014 Sep; 71(9):833-8. PubMed ID: 25282781 [TBL] [Abstract][Full Text] [Related]
43. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498 [TBL] [Abstract][Full Text] [Related]
44. Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice. Wang H; Zhang H; Cao F; Lu J; Tang J; Li H; Zhang Y; Feng B; Tang Z Mol Med Rep; 2018 Nov; 18(5):4577-4586. PubMed ID: 30221656 [TBL] [Abstract][Full Text] [Related]
45. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. Kiziltan ME; Gunduz A; Kiziltan G; Akalin MA; Uzun N J Neurol Sci; 2007 Jul; 258(1-2):75-9. PubMed ID: 17399742 [TBL] [Abstract][Full Text] [Related]
46. Comparison of nerve conduction studies with diabetic neuropathy symptom score and diabetic neuropathy examination score in type-2 diabetics for detection of sensorimotor polyneuropathy. Asad A; Hameed MA; Khan UA; Butt MU; Ahmed N; Nadeem A J Pak Med Assoc; 2009 Sep; 59(9):594-8. PubMed ID: 19750851 [TBL] [Abstract][Full Text] [Related]
48. VEGF gene transfer for diabetic neuropathy. Isner JM; Ropper A; Hirst K Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248 [TBL] [Abstract][Full Text] [Related]
49. Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease: study protocol for a randomized controlled trial. Jin D; Huang WJ; Meng X; Yang F; Zheng YJ; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL Trials; 2017 Dec; 18(1):631. PubMed ID: 29284520 [TBL] [Abstract][Full Text] [Related]
50. Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy. Adams D; Suhr OB; Dyck PJ; Litchy WJ; Leahy RG; Chen J; Gollob J; Coelho T BMC Neurol; 2017 Sep; 17(1):181. PubMed ID: 28893208 [TBL] [Abstract][Full Text] [Related]
51. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome. Engel WK Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499 [TBL] [Abstract][Full Text] [Related]
53. Nerve growth factor promising in diabetic neuropathy...and in HIV-1-related neuropathy. Larkin M Lancet; 1998 Sep; 352(9133):1039. PubMed ID: 9759757 [No Abstract] [Full Text] [Related]
54. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement]. Shimada H; Miki T; Kyogoku I; Kawagishi T; Inaba M; Okuno Y; Nishizawa Y; Morii H No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304 [TBL] [Abstract][Full Text] [Related]
55. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ; Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243 [TBL] [Abstract][Full Text] [Related]